COVID-19 in pediatric nephrology centers in Turkey

Simple item page
dc.contributor.authorEmre LEVENTOĞLU
dc.contributor.authorYeşim ÖZDEMİR ATİKEL
dc.contributor.authorHülya NALCACIOĞLU
dc.contributor.authorİsmail DURSUN
dc.contributor.authorHasan DURSUN
dc.contributor.authorZeynep YÜRÜK YILDIRIM
dc.contributor.authorNurdan YILDIZ
dc.contributor.authorGulsah kaya AKSOY
dc.contributor.authorMehmet TAŞDEMİR
dc.contributor.authorMehtap Ezel ÇELAKIL
dc.contributor.authorBeltinge DEMİRCİOĞLU KILIÇ
dc.contributor.authorSenay Zirhli Selcuk
dc.contributor.authorNur CANPOLAT
dc.contributor.authorEvrim KARGIN ÇAKICI
dc.contributor.authorSare Gülfem ÖZLÜ
dc.contributor.authorSebahat TÜLPAR
dc.contributor.authorSelçuk YÜKSEL
dc.contributor.authorBahriye ATMIŞ
dc.contributor.authorSerra SÜRMELİ DÖVEN
dc.contributor.authorSevgin TANER
dc.contributor.authorPelin ERTAN
dc.contributor.authorAslı KAVAZ TUFAN
dc.contributor.authorMeral TORUN BAYRAM
dc.contributor.authorMukaddes KALYONCU
dc.contributor.authorKaan Savaş GÜLLEROĞLU
dc.contributor.authorCaner KABASAKAL
dc.contributor.authorBelde DEMİR
dc.contributor.authorRumeysaYasemin Cicek
dc.contributor.authorİlmay BİLGE
dc.contributor.authorOsman DÖNMEZ
dc.contributor.authorAslihan KARA
dc.contributor.authorÖnder YAVAŞCAN
dc.contributor.authorGül ÖZÇELİK
dc.contributor.authorDeniz GEZGİN YILDIRIM
dc.contributor.authorMuhammet Akif GÜLER
dc.contributor.authorFerah SÖNMEZ
dc.contributor.authorMuammer Hakan Poyrazoğlu
dc.contributor.authorSema AKMAN
dc.contributor.authorRezan TOPALOĞLU
dc.contributor.authorHarika ALPAY
dc.contributor.authorSevcan A BAKKALOĞLU
dc.date.accessioned2024-07-24T09:11:59Z
dc.date.available2024-07-24T09:11:59Z
dc.date.issued2022
dc.description.abstractBackground/aim: There is limited data on COVID-19 disease in children with kidney disease. We aimed to investigate the characteristics and prognosis of COVID-19 in pediatric nephrology patients in Turkey. Materials and methods: This was a national, multicenter, retrospective cohort study based on an online survey evaluating the data between 11th March 2020 and 11th March 2021 as an initial step of a detailed pediatric nephrology COVID-19 registry. Results: Two hundred and three patients (89 girls and 114 boys) were diagnosed with COVID-19. One-third of these patients (36.9%) were between 10–15 years old. Half of the patients were on kidney replacement therapy: kidney transplant (KTx) recipients (n = 56, 27.5%), patients receiving chronic hemodialysis (n = 33, 16.3%) and those on peritoneal dialysis (PD) (n = 18, 8.9%). Fifty-four (26.6%) children were asymptomatic. Eighty-two (40.3%) patients were hospitalized and 23 (28%) needed intensive care unit admission. Fifty- five percent of the patients were not treated, while the remaining was given favipiravir (20.7%), steroid (16.3%), and hydroxychloroquine (11.3%). Acute kidney injury developed in 19.5% of hospitalized patients. Five (2.4%) had MIS-C. Eighty-three percent of the patients were discharged without any apparent sequelae, while 7 (3.4%) died. One hundred and eight health care staff were infected during the study period. Conclusion: COVID-19 was most commonly seen in patients who underwent KTx and received HD. The combined immunosuppressive therapy and frequent exposure to the hospital setting may increase these patients’ susceptibility. Staff infections before vaccination era were alarming, various precautions should be taken for infection control, particularly optimal vaccination coverage.
dc.identifier.DOI-ID10.55730/1300-0144.5521
dc.identifier.issn1300-0144
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/24136
dc.language.isoeng
dc.titleCOVID-19 in pediatric nephrology centers in Turkey
dc.typeAraştırma Makalesi

Files

Collections

TR-Dizin Koleksiyonu